Search

Search Constraints

You searched for: Author/Creator Mazor, Tali

Search Results

1. Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Issue 5 (25th October 2017)

2. GENE-47. A 3D ATLAS TO EVALUATE THE SPATIAL PATTERNING OF GENETIC ALTERATIONS AND TUMOR CELL STATES IN GLIOMA. (11th November 2019)

3. PATH-29. CLINICAL SIGNIFICANCE OF TEMOZOLOMIDE-INDUCED SOMATIC HYPERMUTATION IN INITIALLY LOW-GRADE IDH-MUTANT DIFFUSE GLIOMAS. (5th November 2018)

4. Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas. Issue 11 (5th April 2021)

5. OncoTree: A Cancer Classification System for Precision Oncology. (2021)

6. PATH-12. TEMOZOLOMIDE-INDUCED HYPERMUTATION IS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION, DISTANT RECURRENCE AND REDUCED SURVIVAL IN INITIALLY LOW GRADE IDH-MUTANT GLIOMAS. (9th November 2020)

7. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Issue 1 (16th July 2020)

8. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Issue 7 (12th March 2018)

9. Probing the phosphatidylinositol 3‐kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low‐grade gliomas. Issue 23 (31st July 2017)